{"name":"Celator Pharmaceuticals","permalink":"celator-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/celator-pharmaceuticals","homepage_url":"http://www.celatorpharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@celatorpharma.com","phone_number":"(609) 243-0123","description":"","created_at":"Thu Sep 02 14:13:55 UTC 2010","updated_at":"Thu Sep 02 14:13:54 UTC 2010","overview":"<p>Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.</p>","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/0352/100352v1-max-150x150.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-250x250.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Scott","last_name":"Jackson","permalink":"scott-jackson","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$20M","funding_rounds":[{"round_code":"d","source_url":"http://www.celatorpharma.com/new/pr_20100901.html","source_description":"CELATORÂ® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"investments":[{"company":null,"financial_org":{"name":"Thomas, McNerney & Partners","permalink":"thomas-mcnerney-partners","image":{"available_sizes":[[[150,18],"assets/images/resized/0008/1733/81733v1-max-150x150.png"],[[250,30],"assets/images/resized/0008/1733/81733v1-max-250x250.png"],[[450,54],"assets/images/resized/0008/1733/81733v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Ventures West","permalink":"ventures-west","image":{"available_sizes":[[[150,46],"assets/images/resized/0001/0785/10785v1-max-150x150.png"],[[240,74],"assets/images/resized/0001/0785/10785v1-max-250x250.png"],[[240,74],"assets/images/resized/0001/0785/10785v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"TL Ventures","permalink":"tl-ventures","image":{"available_sizes":[[[150,45],"assets/images/resized/0003/0750/30750v1-max-150x150.png"],[[208,63],"assets/images/resized/0003/0750/30750v1-max-250x250.png"],[[208,63],"assets/images/resized/0003/0750/30750v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"GrowthWorks Capital","permalink":"growthworks","image":{"available_sizes":[[[150,38],"assets/images/resized/0002/8728/28728v1-max-150x150.png"],[[187,48],"assets/images/resized/0002/8728/28728v1-max-250x250.png"],[[187,48],"assets/images/resized/0002/8728/28728v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"BDC Venture Capital","permalink":"bdc-venture-capital-2","image":{"available_sizes":[[[115,57],"assets/images/resized/0001/1190/11190v1-max-150x150.png"],[[115,57],"assets/images/resized/0001/1190/11190v1-max-250x250.png"],[[115,57],"assets/images/resized/0001/1190/11190v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":" 303B College Road East ","address2":"","zip_code":"08540","city":"Princeton","state_code":"NJ","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}